Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival

World Journal of Urology

Volumn 32, Issue 2, 2014, Pages 475-479

  Bourgade, Vincent ^a,b,c   Drouin, Sarah J ^a,b,c   Yates, David R ^a,b,c   Parra, Jerôme ^a,b,c   Bitker, Marc Olivier ^a,b,c   Cussenot, Olivier ^a,b,c   Rouprêt, Morgan ^a,b,c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSTITUT UNIVERSITAIRE DE FRANCE   (France)

Author keywords

Prostate cancer; Renal cell carcinoma; Surgery; Survival; Urothelial carcinoma; Waiting time

Indexed keywords

ARTICLE; BLADDER TUMOR; CYSTECTOMY; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; METHODOLOGY; MORTALITY; NEOPLASM; NEPHRECTOMY; ORCHIECTOMY; PENIS TUMOR; PROSTATE TUMOR; PROSTATECTOMY; TESTIS TUMOR; TIME; TIME TO TREATMENT; TRANSITIONAL CELL CARCINOMA; URETER TUMOR; URINARY TRACT CANCER;

CARCINOMA, RENAL CELL; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; HUMANS; KIDNEY NEOPLASMS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; NEPHRECTOMY; ORCHIECTOMY; PENILE NEOPLASMS; PROSTATECTOMY; PROSTATIC NEOPLASMS; TESTICULAR NEOPLASMS; TIME FACTORS; TIME-TO-TREATMENT; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS; UROLOGIC NEOPLASMS;

EID: 84897073050     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-013-1045-z     Document Type: Article

References (39)

1. Siegel R, Desantis C, Virgo K, Stein K, Mariotto A, Smith T et al (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62: 220-241.
2. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
3. Yates DR, Roupret M (2013) Comparing how significantly the pharmacological treatment of genitourinary cancer in a non-curative setting affects endpoints of survival or response. World J Urol 31: 117-125.
4. Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L et al (2008) Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358: 1250-1261.
5. Bill-Axelson A, Holmberg L, Ruutu M, Garmo H, Stark JR, Busch C et al (2011) Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 364: 1708-1717.
6. Gill IS, Aron M, Gervais DA, Jewett MA (2010) Clinical practice. Small renal mass. N Engl J Med 362: 624-634.
7. Ljungberg B, Hanbury DC, Kuczyk MA, Merseburger AS, Mulders PF, Patard JJ et al (2007) Renal cell carcinoma guideline. Eur Urol 51: 1502-1510.
8. Roupret M (2008) Treatment waiting time in urological oncology. Prog Urol 18: 426-427.
9. Neuzillet Y, Correas JM, Escudier B, de Fromont M, Lang H, Long JA et al (2008) What may be the waiting time between the diagnosis and surgical treatment of kidney cancer? Prog Urol 18: 197-203.
10. Spurgeon P, Barwell F, Kerr D (2000) Waiting times for cancer patients in England after general practitioners' referrals: retrospective national survey. BMJ 320: 838-839.
11. Konety BR, Dhawan V, Allareddy V, Joslyn SA (2005) Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project. J Urol 173: 1695-1700.
12. Volpe A, Cadeddu JA, Cestari A, Gill IS, Jewett MA, Joniau S et al (2011) Contemporary management of small renal masses. Eur Urol 60: 501-515.
13. Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MA (2004) The natural history of incidentally detected small renal masses. Cancer 100: 738-745.
14. Consensus document: recommendations for optimal surgical wait times for patients with urological malignancies. Can J Urol 13 Suppl 3: 62-4 (2006).
15. Abouassaly R, Yang S, Finelli A, Kulkarni GS, Alibhai SM (2011) What is the best treatment strategy for incidentally detected small renal masses? A decision analysis. BJU Int 108: E223-E231.
16. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG (2006) The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 175: 425-431.
17. van Poppel H, Joniau S (2007) Is surveillance an option for the treatment of small renal masses? Eur Urol 52: 1323-1330.
18. Lane BR, Tobert CM, Riedinger CB (2012) Growth kinetics and active surveillance for small renal masses. Curr Opin Urol 22: 353-359.
19. Zhang J, Pan JH, Dong BJ, Xue W, Liu DM, Huang YR (2012) Active surveillance of renal masses in von Hippel-Lindau disease: growth rates and clinical outcome over a median follow-up period of 56 months. Fam Cancer 11: 209-214.
20. Dickinson AJ, Howe K, Bedford C, Sanders T, Prentice A, Sibley GN (1996) A retrospective study of the investigation and management of muscle-invasive bladder cancer in the South West Region. Br J Urol 77: 70-75.
21. Wallace DM, Bryan RT, Dunn JA, Begum G, Bathers S (2002) Delay and survival in bladder cancer. BJU Int 89: 868-878.
22. Gore JL, Lai J, Setodji CM, Litwin MS, Saigal CS (2009) Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a surveillance, epidemiology, and end results-medicare analysis. Cancer 115: 988-996.
23. Kulkarni GS, Urbach DR, Austin PC, Fleshner NE, Laupacis A (2009) Longer wait times increase overall mortality in patients with bladder cancer. J Urol 182: 1318-1324.
24. Lee CT, Madii R, Daignault S, Dunn RL, Zhang Y, Montie JE et al (2006) Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival. J Urol 175: 1262-1267 discussion 1267.
25. Sundi D, Svatek RS, Margulis V, Wood CG, Matin SF, Dinney CP et al (2012) Upper tract urothelial carcinoma: impact of time to surgery. Urol Oncol 30: 266-272.
26. Nison L, Roupret M, Bozzini G, Ouzzane A, Audenet F, Pignot G, et al. (2012) The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database. World J Urol 31(1): 69-76.
27. Gadzinski AJ, Roberts WW, Faerber GJ, Wolf JS Jr (2012) Long-term outcomes of immediate versus delayed nephroureterectomy for upper tract urothelial carcinoma. J Endourol 26: 566-573.
28. Waldert M, Karakiewicz PI, Raman JD, Remzi M, Isbarn H, Lotan Y et al (2010) A delay in radical nephroureterectomy can lead to upstaging. BJU Int 105: 812-817.
29. Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V et al (2011) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59: 61-71.
30. Vickers AJ, Bianco FJ Jr, Boorjian S, Scardino PT, Eastham JA (2006) Does a delay between diagnosis and radical prostatectomy increase the risk of disease recurrence? Cancer 106: 576-580.
31. Korets R, Seager CM, Pitman MS, Hruby GW, Benson MC, McKiernan JM (2012) Effect of delaying surgery on radical prostatectomy outcomes: a contemporary analysis. BJU Int 110: 211-216.
32. van den Bergh RC, Steyerberg EW, Khatami A, Aus G, Pihl CG, Wolters T et al (2010) Is delayed radical prostatectomy in men with low-risk screen-detected prostate cancer associated with a higher risk of unfavorable outcomes? Cancer 116: 1281-1290.
33. Subramonian KR, Puranik S, Mufti GR (2003) How will the two-weeks-wait rule affect delays in management of urological cancers? J R Soc Med 96: 398-399.
34. Germa JR, Garcia Del Muro X, Maroto P, Lianes P, Arranz JA, Guma J et al (2001) Clinical pattern and therapeutic results obtained in Germ-Cell testicular cancer in Spain based on a consecutive series of 1250 patients. Med Clin (Barc) 116: 481-486.
35. Harding M, Paul J, Kaye SB (1995) Does delayed diagnosis or scrotal incision affect outcome for men with non-seminomatous germ cell tumours? Br J Urol 76: 491-494.
36. Bell D, Morash C, Dranitsaris G, Izawa J, Short T, Klotz LH et al (2006) Does prolonging the time to testicular cancer surgery impact long-term cancer control: a systematic review of the literature. Can J Urol 13(Suppl 3): 30-36.
37. Derrett S, Paul C, Morris JM (1999) Waiting for elective surgery: effects on health-related quality of life. Int J Qual Health Care 11: 47-57.
38. Hawary AM, Warburton HE, Brough RJ, Collins GN, Brown SC, O'Reilly PH et al (2008) The '2-week wait' rule for referrals for suspected urological cancers-urgent need for refinement of criteria. Ann R Coll Surg Engl 90: 517-522.
39. Bilimoria KY, Tomlinson JS, Stewart AK, Talamonti MS, Hynes DL, Winchester DP et al (2011) Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg 253: 779-785.